Manufactur standard Tilmicosin Swine - Enrofloxacin tablet-racing pigeon medicine – Depond
Manufactur standard Tilmicosin Swine - Enrofloxacin tablet-racing pigeon medicine – Depond Detail:
Composition: Enroflxoacin 10mg per tablet
Description: Enrofloxacin is a synthetic chemotherapeutic agent from the quinolone class of drugs. It has antibactericidal activity against a broad spectrum of gram + and gram – bacteria. It is rapidly absorbed and penetrates all body tissues well
Indication: For Gastrointestinal infection, respiratory infection, urinary tract infection. which is casued by the bacterial sensitive to enrofloxacin.
Adverse reactions: Enrofloxacin causes increased mortality in the egg when the hen is treated during egg formation. It will cause cartilage abnormalities in growing squabs, especially during the 1st week to 10 days of age. This. however, is not always seen.
Dosage: 5 – 10 mg/bird divided daily for 7 – 14 days. 150 – 600 mg/gallon for 7 – 14 days.
Storage: Avoid humidity, keep in cool and dry place.
Package: 10 tablets/blister, 10 blisters/box
Product detail pictures:
Related Product Guide:
The organization upholds the philosophy of "Be No.1 in good quality, be rooted on credit history and trustworthiness for growth", will keep on to provide previous and new customers from home and overseas whole-heatedly for Manufactur standard Tilmicosin Swine - Enrofloxacin tablet-racing pigeon medicine – Depond , The product will supply to all over the world, such as: Thailand, Mali, Belarus, We have top engineers in these industries and an efficient team in the research. What is more, we have our own archives mouths and markets in China at low cost. Therefore, we can meet different inquiries from different clients. Please find our website to check more information from our products.
By Frank from Algeria - 2017.03.28 12:22
The quality of the products is very good, especially in the details, can be seen that the company work actively to satisfy customer's interest, a nice supplier.
By Maud from Bangladesh - 2017.02.14 13:19
